For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...

In a 2023 position statement, the Menopause Society recommended clinical hypnosis for vasomotor symptoms, and other ...

Cordis, a global leader in interventional cardiovascular technology, announced the groundbreaking results from the SELUTION ...

Black and Hispanic individuals with obesity appear underrepresented in GLP-1 weight loss trials, compared with the overall ...

The American Academy of Pediatrics declined to recommend routine use of leucovorin for children with autism spectrum disorder ...

A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...

M is positioned as the first oral antiviral sugar chemistry drug BOSTON, MASSACHUSETTS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC.

In two multicenter trials, separate balloon angioplasty platforms were noninferior to lithotripsy for treatment of calcified coronary lesions but substantially less costly.

Advances development of ninerafaxstat, a potential first-in-class therapy designed to improve cardiac energetics in patients with serious cardiovascular diseases Enrollment underway across U.S. sites ...